AMAL insider trades: option exercises, sale, and 2,311 RSU grant

Rhea-AI Filing Summary

Amalgamated Financial Corp. (AMAL) disclosed insider activity by a director. On 10/30/2025, the director exercised non-qualified stock options for 4,820 shares at $12, 4,220 shares at $13.75, and 3,960 shares at $14.65. To cover taxes, the issuer withheld 2,340 shares, 2,048 shares, and 1,922 shares at $27.5575.

On 10/31/2025, the director sold 6,697 shares at a weighted average price of $27.3424 (footnote: trades ranged from $27.065 to $27.63). On 11/01/2025, the director received 2,311 restricted stock units that vest immediately, in consideration of the company’s termination of the stock option program and the director’s early exercise of all outstanding and vested options on 10/30/2025. Following these transactions, the director beneficially owned 19,074 shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Romney Edgar

(Last) (First) (Middle)

275 7TH AVE

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amalgamated Financial Corp. [ AMAL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/30/2025		M		4,820	A	$12	21,590	D
Common Stock	10/30/2025		F		2,340	D	$27.5575	19,250	D
Common Stock	10/30/2025		M		4,220	A	$13.75	23,470	D
Common Stock	10/30/2025		F		2,048	D	$27.5575	21,422	D
Common Stock	10/30/2025		M		3,960	A	$14.65	25,382	D
Common Stock	10/30/2025		F		1,922	D	$27.5575	23,460	D
Common Stock	10/31/2025		S		6,697	D	$27.3424(1)	16,763	D
Common Stock	11/01/2025		A		2,311	A	$0	19,074(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$12	10/30/2025		M			4,820	01/01/2016	01/01/2026	Common Stock	4,820	$0	0	D
Non-Qualified Stock Option (right to buy)	$13.75	10/30/2025		M			4,220	01/01/2017	01/01/2027	Common Stock	4,220	$0	0	D
Non-Qualified Stock Option (right to buy)	$14.65	10/30/2025		M			3,960	01/01/2018	01/01/2028	Common Stock	3,960	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.065 - $27.63 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4

2. The reported transaction involved the reporting person's receipt of a grant of 2,311 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.

Remarks:

	/s/ Edgar Romney, Sr.	11/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did AMAL (AMAL) report?

A director exercised stock options, had shares withheld for taxes, sold shares on 10/31/2025, and received an RSU grant on 11/01/2025.

How many AMAL shares were sold and at what price?

The director sold 6,697 shares at a weighted average price of $27.3424, with trade prices ranging from $27.065 to $27.63.

What stock options were exercised by the AMAL director?

On 10/30/2025, options for 4,820 shares at $12, 4,220 shares at $13.75, and 3,960 shares at $14.65 were exercised.

What tax withholdings occurred for the AMAL director?

To cover taxes, 2,340, 2,048, and 1,922 shares were withheld at $27.5575 on 10/30/2025.

What RSU grant did the AMAL director receive?

On 11/01/2025, the director received 2,311 RSUs that vested immediately, tied to ending the stock option program and early option exercises on 10/30/2025.

What is the AMAL director’s ownership after these transactions?

Following the reported transactions, the director directly owned 19,074 shares.